Probiotic Lactobacillus fermentum UCO-979C biofilm formation on AGS and Caco-2 cells and Helicobacter pylori inhibition

Biofouling. 2016 Nov;32(10):1245-1257. doi: 10.1080/08927014.2016.1249367.

Abstract

The ability of the human isolate Lactobacillus fermentum UCO-979C to form biofilm and synthesize exopolysaccharide on abiotic and biotic models is described. These properties were compared with the well-known Lactobacillus casei Shirota to better understand their anti-Helicobacter pylori probiotic activities. The two strains of lactobacilli synthesized exopolysaccharide as detected by the Dubois method and formed biofilm on abiotic and biotic surfaces visualized by crystal violet staining and scanning electron microscopy. Concomitantly, these strains inhibited H. pylori urease activity by up to 80.4% (strain UCO-979C) and 66.8% (strain Shirota) in gastric adenocarcinoma (AGS) cells, but the two species showed equal levels of inhibition (~84%) in colorectal adenocarcinoma (Caco-2) cells. The results suggest that L. fermentum UCO-979C has probiotic potential against H. pylori infections. However, further analyses are needed to explain the increased activity observed against the pathogen in AGS cells as compared to L. casei Shirota.

Keywords: AGS cells; Caco-2 cells; Helicobacter pylori; Lactobacillus fermentum.

MeSH terms

  • Antibiosis*
  • Bacterial Adhesion
  • Biofilms / growth & development*
  • Caco-2 Cells
  • Colonic Neoplasms / microbiology
  • Helicobacter pylori / drug effects
  • Helicobacter pylori / growth & development*
  • Humans
  • Lacticaseibacillus casei / metabolism
  • Lacticaseibacillus casei / physiology
  • Limosilactobacillus fermentum / metabolism
  • Limosilactobacillus fermentum / physiology*
  • Microscopy, Electron, Scanning
  • Polysaccharides, Bacterial / analysis
  • Polysaccharides, Bacterial / pharmacology
  • Probiotics* / pharmacology
  • Stomach Neoplasms / microbiology

Substances

  • Polysaccharides, Bacterial